- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: OncoTarget, 10.2019, Nr. 46, S. 4721-4723, doi:10.18632/oncotarget.27094
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2019
- Creator
-
Ronellenfitsch, Michael Wilfried
Luger, Anna-Luisa
Steinbach, Joachim Peter
- URN
-
urn:nbn:de:hebis:30:3-507611
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:55 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ronellenfitsch, Michael Wilfried
- Luger, Anna-Luisa
- Steinbach, Joachim Peter
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2019
Other Objects (12)
SUMOylation in glioblastoma : a novel therapeutic target
Therapeutic Potential of Selenium in Glioblastoma
Neurotransmitters: potential targets in glioblastoma
Endothelial cell‐derived angiopoietin‐2 is a therapeutic target in treatment‐naive and bevacizumab‐resistant glioblastoma
Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma
mTOR inhibitors : initial therapeutic experience in pediatric organ transplant recipients
The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma
The macrophage as therapeutic target
Altersabhängige Expression von p53, MDM2, EGFR und MSH2 im Glioblastoma multiforme
Target therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in tumor-bearing nude mice
Aspartic acid proteases as therapeutic targets
New therapeutic targets in rheumatoid arthritis
SUMOylation in glioblastoma : a novel therapeutic target
Therapeutic Potential of Selenium in Glioblastoma
Neurotransmitters: potential targets in glioblastoma
Endothelial cell‐derived angiopoietin‐2 is a therapeutic target in treatment‐naive and bevacizumab‐resistant glioblastoma
Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma
mTOR inhibitors : initial therapeutic experience in pediatric organ transplant recipients
The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma
The macrophage as therapeutic target
Altersabhängige Expression von p53, MDM2, EGFR und MSH2 im Glioblastoma multiforme
Target therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in tumor-bearing nude mice
Aspartic acid proteases as therapeutic targets
New therapeutic targets in rheumatoid arthritis
SUMOylation in glioblastoma : a novel therapeutic target
Therapeutic Potential of Selenium in Glioblastoma
Neurotransmitters: potential targets in glioblastoma
Endothelial cell‐derived angiopoietin‐2 is a therapeutic target in treatment‐naive and bevacizumab‐resistant glioblastoma
Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma
mTOR inhibitors : initial therapeutic experience in pediatric organ transplant recipients
The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma
The macrophage as therapeutic target
Altersabhängige Expression von p53, MDM2, EGFR und MSH2 im Glioblastoma multiforme
Target therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in tumor-bearing nude mice
Aspartic acid proteases as therapeutic targets